BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12838310)

  • 1. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients.
    Petry KU; Menton S; Menton M; van Loenen-Frosch F; de Carvalho Gomes H; Holz B; Schopp B; Garbrecht-Buettner S; Davies P; Boehmer G; van den Akker E; Iftner T
    Br J Cancer; 2003 May; 88(10):1570-7. PubMed ID: 12771924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
    Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
    PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
    Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
    Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia.
    Nuovo GJ; Blanco JS; Leipzig S; Smith D
    Obstet Gynecol; 1990 Jun; 75(6):1006-11. PubMed ID: 2160630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Colposcopic Biopsy Results of Patients Who have Cytomorphological Normal but HPV 16-18 or Other High-Risk HPV Subtypes Positive.
    Aydoğmuş H; Aydoğmuş S
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):417-420. PubMed ID: 30803201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human papilloma virus in women referred for colposcopy. A comparison between different diagnostic methods.
    Bodén E; Evander M; Wadell G; Bjersing L; von Schoultz B; Rylander E
    Acta Obstet Gynecol Scand; 1990; 69(2):153-9. PubMed ID: 2166988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of CIN2+ diagnoses and conizations in women aged 18-45 years-a retrospective secondary data analysis of German statutory health insurance claims data.
    Reuschenbach M; Stephan AJ; Saxena K; Prabhu VS; Jacob C; Schneider KM; Greiner W; Wölle R; Hampl M
    Arch Gynecol Obstet; 2022 Dec; 306(6):2077-2092. PubMed ID: 35420356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.
    Banović M; Mahovlić V; Salopek KM; Banović V; Babić I; Orešković S; Babić D
    Pathol Oncol Res; 2015 Jul; 21(3):613-7. PubMed ID: 25432549
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.
    Park JY; Bae J; Lim MC; Lim SY; Lee DO; Kang S; Park SY; Nam BH; Seo SS
    J Gynecol Oncol; 2009 Jun; 20(2):86-90. PubMed ID: 19590718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3.
    Almog B; Gamzu R; Bornstein J; Levin I; Fainaru O; Niv J; Lessing JB; Bar-Am A
    Br J Cancer; 2003 Jul; 89(1):109-12. PubMed ID: 12838310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
    Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
    Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic implications of adding HPV tests to the routine cytology follow-up and management of patients with histologically defined cervical intraepithelial neoplasia grade 1.
    Gamzu R; Almog B; Levin I; Fainaru O; Niv J; Lessing JB; Bar-Am A
    Gynecol Oncol; 2002 Aug; 86(2):129-33. PubMed ID: 12144817
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.